Elevation Pharmaceuticals Receives $17,000,000 Series A Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fe54e9a4-c4d7-4f34-b60d-b07cdaa80c77&Preview=1 - Date
9/26/2011 - Company Name
Elevation Pharmaceuticals - Mailing Address
11455 El Camino Real San Diego, CA 92130 - Company Description
Founded in 2008, Elevation Pharmaceuticals is developing a pipeline of improved aerosol drug products for COPD patients. Our founding team has a successful track record starting companies and building dedicated teams to develop new drug products that improve patients’ lives. - Website
http://www.elevationpharma.com - Transaction Type
Venture Equity - Transaction Amount
$17,000,000 - Transaction Round
Series A - Proceeds Purposes
The funding will be used to pay for an ongoing mid-stage study of its experimental drug EP-101. - M&A Terms
- Venture Investor
Canaan Partners - Venture Investor
TPG Capital - Venture Investor
Care Capital - Venture Investor
Mesa Verde Venture Partners
